Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE StudyNeoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorderActive, not recruitingPhase 22026-09-14NCT04316117

2 results · Page 1 of 1

Swipe the table sideways for more columns.

104 results · Page 1 of 5

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Abbott-Northwestern HospitalMinneapolisUnited States254
Bayhealth Hospital Kent CampusDoverUnited States30
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer CenterHoustonUnited States163
Bryn Mawr HospitalBryn MawrUnited States87
Cancer Care Specialists of Illinois - DecaturDecaturUnited States267
Cancer Center at Saint Joseph'sPhoenixUnited States134
Cancer Center-Metro Medical Center BayamonBayamónPuerto Rico45
Carle at The RiverfrontDanvilleUnited States258
Carle Cancer CenterUrbanaUnited States323
Carle Physician Group-EffinghamEffinghamUnited States268
Carle Physician Group-Mattoon/CharlestonMattoonUnited States277
Centro Comprensivo de Cancer de UPRSan JuanPuerto Rico74
Cooper Hospital University Medical CenterCamdenUnited States89
Cork University HospitalCorkIreland34
CoxHealth South HospitalSpringfieldUnited States198
Dana-Farber Cancer InstituteBostonUnited States626
Decatur Memorial HospitalDecaturUnited States303
Doctors Cancer CenterManatiPuerto Rico57
Emory Saint Joseph's HospitalAtlantaUnited States175
Emory University Hospital MidtownAtlantaUnited States246
Emory University Hospital/Winship Cancer InstituteAtlantaUnited States299
FHCC South Lake UnionSeattleUnited States16
Fox Chase Cancer CenterPhiladelphiaUnited States259
Fred Hutchinson Cancer Research CenterSeattleUnited States71
Geisinger Medical CenterDanvilleUnited States274